Type 2 diabetes: open trials in Australia

33 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Trial Treatment · Phase 3 · Eli Lilly and Company
Emeritus Research, Botany · Box Hill Hospital, Box Hill · Royal Brisbane and Women's Hospital, Brisbane · Emeritus Research, Camberwell · Barwon Health, Geelong · Austin Health - Repatriation Hospital, Heidelberg West · Aim Research, Merewether · Southern Adelaide Diabetes & Endocrine Services, Oaklands Park · Royal North Shore Hospital, St Leonards · Innovate Clinical Research, Waitara
Registry updated 2026-11-04
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Nightingale Research, Adelaide · Box Hill Hospital, Box Hill · Royal Brisbane and Women's Hospital, Brisbane · Nightingale Research - Frankston, Frankston · Canberra Hospital, Garran · Life Clinical Research, Ipswich · Ipswich Hospital, Ipswich · Momentum Sunshine, Melbourne · Paratus Clinical Research - Melbourne, Melbourne · Royal North Shore Hospital, St Leonards · Innovate Clinical Research, Waitara
Registry updated 2026-11-03
NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Botany · Camberwell · Charlestown · St Albans · St Leonards · Waitara
Registry updated 2026-10-30
NCT07754461
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Trial Treatment · Phase 3 · Boehringer Ingelheim
Royal Prince Alfred Hospital, Camperdown · Logan Hospital, Meadowbrook · Baker Heart and Diabetes Institute, Melbourne · Southern Adelaide Diabetes & Endocrine Services, Oaklands Park
Registry updated 2026-10-29
NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Nightingale Research Pty Ltd, Adelaide · Flinders Medical Centre, Bedford Park · Blacktown Hospital, Blactown · Advara Heartcare Research Burwood, Burwood · Royal Prince Alfred Hospital, Camperdown · Heart of Australia, Chelmer · Prince Charles Hospital, Chermside · Monash Health, Clayton · Concord Repatriation General Hospital, Concord · The Northern Hospital, Epping · Nightingale Research Victoria, Frankston · Canberra Hospital, Garran · Royal Brisbane and Women's Hospital, Herston · Royal Hobart Hospital, Hobart · Heartwest, Hoppers Crossing · Life Clinical Research, Ipswich · Advara Heartcare Research WA, Joondalup · Advara Heart Care-Leabrook-69072, Leabrook · Sydney Cardiometabolic Centre, Liverpool · Cabrini Health, Malvern · Advara HeartCare Mulgrave, Mulgrave · Fiona Stanley Hospital, Murdoch · John Hunter Hospital, New Lambton Heights · Gold Coast University Hospital, Southport · Royal North Shore Hospital, St Leonards · St. John of God Subiaco Hospital, Subiaco · Toowoomba Hospital, Toowoomba
Registry updated 2026-10-28
NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Trial Treatment · Phase 3 · AstraZeneca
Botany · Camberwell · Charlestown · Helensvale · Maroubra · Waitara
Registry updated 2026-10-28
NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Botany · East Toowoomba · Fitzroy · Heidelberg Heights · Kingswood · Melbourne · Parkville · Penrith · St Leonards
Registry updated 2026-10-22
NCT07197788
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Trial Treatment · Endogenex, Inc.
St Vincent's Hospital Melbourne, Fitzroy · Baker Heart and Diabetes Institute, Melbourne · The BMI Clinic, Randwick
Registry updated 2026-10-19
NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Paratus Clinical Western Sydney, Blacktown · Heidelberg Repatriation Hospital, Heidelberg · Baker Heart and Diabetes Insitute, Melbourne · Southern Adelaide Diabetes and Endocrine Services (SADES), Oaklands Park · Royal North Shore Hospital, St Leonards
Registry updated 2026-10-13
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Paratus Clinical Western Sydney, Blacktown · Royal Prince Alfred Hospital, Camperdown · Heidelberg Repatriation Hospital, Heidelberg · Logan Hospital, Meadowbrook · Baker Heart and Diabetes Insitute, Melbourne · Southern Adelaide Diabetes and Endocrine Services (SADES), Oaklands Park
Registry updated 2026-10-13
NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Trial Treatment · Phase 3 · AstraZeneca
Botany · Camberwell · Charlestown · Maroubra · St Albans · St Leonards
Registry updated 2026-10-13
NCT07668388
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Trial Treatment · Phase 2 · Novo Nordisk A/S
Royal Adelaide Hospital - Cardiology Department, Adelaide · Castle Hill Medical Centre, Castle Hill · Novatrials, Charlestown · Baker Heart and Diabetes Institute, Melbourne · Hunter Medical Research Institute - Endocrinology and Diabetes, New Lambton Heights · Roger Chih Yu Chen, Sydney
Registry updated 2026-10-07
NCT05633810
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Trial Treatment · Phase 3 · Montreal Heart Institute
Curtin University, Bentley
Registry updated 2026-10-06
NCT07829302
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
Trial Treatment · Phase 1/2 · Kriya Therapeutics, Inc.
Melbourne
Registry updated 2026-10-05
NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Trial Treatment · Phase 3 · Novo Nordisk A/S
University of Sunshine Coast - Vitality Village, Birtinya · Emeritus Research Melbourne, Camberwell · Sydney Clinical Trials, Campbelltown · Gosford Renal Research, Gosford · Sydney Cardiometabolic Centre, Liverpool · Hunter Diabetes Centre, Merewether · University of Sunshine Coast - South Brisbane, South Brisbane
Registry updated 2026-09-30
NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Emeritus Research, Botany · Core Research Group, Brisbane · Emeritus Research, Camberwell · Life Clinical Research, Ipswich · Paratus Clinical Research Central Coast, Kanwal · University of the Sunshine Coast (UniSC) Clinical Trials - Meadowbrook, Meadowbrook · Paratus Clinical Research - Melbourne, Melbourne · Momentum Sunshine, Melbourne · Aim Research, Merewether · Fusion Clinical Research, Norwood · USC Clinical Trials Sunshine Coast, Sippy Downs
Registry updated 2026-09-22
NCT06820281
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Trial Treatment · Phase 2 · Victor Chang Cardiac Research Institute
Victor Chang Cardiac Research Institute, Sydney
Registry updated 2026-09-16
NCT07664553
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Trial Treatment · Phase 3 · AstraZeneca
Campbelltown · East Toowoomba · Heidelberg Heights · Parkville · St Leonards
Registry updated 2026-08-04
NCT06937203
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 1/2 · Arrowhead Pharmaceuticals
Morayfield · Nedlands
Registry updated 2026-07-08
NCT07139405
TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy
Trial Treatment · Phase 2 · Myopharm Limited
UniSC Clinical Trials, Maroochydore · Momentum Sunshine, Melbourne · Momentum Darlinghurst, Sydney
Registry updated 2026-07-08
NCT07197775
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Research · Endogenex, Inc.
St Vincent's Hospital Melbourne, Fitzroy
Registry updated 2026-07-01
NCT06579404
Closed-loop in Adults With Type 2 Diabetes
Trial Treatment · University of Cambridge
University of Melbourne, Melbourne
Registry updated 2026-03-13
NCT06717698
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Trial Treatment · Phase 2 · Novo Nordisk A/S
Castle Hill Medical Centre, Castle Hill · Heart of Australia, Chelmer · Gosford Renal Research, Gosford · Melbourne Renal Research Group, Reservoir · Sunshine Hospital - Western Centre for Health Research and Education, St Albans
Registry updated 2026-03-11
NCT06942195
Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes
Trial Treatment · University of Adelaide
Clinical Research Facility, Adelaide Health and Medical Sciences Building, Adelaide
Registry updated 2025-12-26
NCT07225465
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin
Trial Treatment · Phase 2 · St Vincent's Hospital Melbourne
St Vincent's Hospital Melbourne, Fitzroy · Austin Health, Heidelberg · Baker Heart and Diabetes Institute, Melbourne · The Royal Melbourne Hospital, Parkville
Registry updated 2025-11-06

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error